Regulation of Vascular Endothelial Growth Factor in endometrial tumour cells by resveratrol and EGCG. (Q46074914)

19 December 2017

title

Regulation of Vascular Endothelial Growth Factor in endometrial tumour cells by resveratrol and EGCG. (English)

1 reference

19 December 2017

0 references

2

Peter H Sykes

1 reference

19 December 2017

John Evans

series ordinal

4

object named as

John J Evans

1 reference

19 December 2017

author name string

James M Dann

series ordinal

1

1 reference

19 December 2017

Drusilla R Mason

series ordinal

3

1 reference

19 December 2017

language of work or name

English

0 references

publication date

25 March 2009

1 reference

19 December 2017

published in

Gynecologic Oncology

1 reference

19 December 2017

volume

113

1 reference

19 December 2017

page(s)

374-378

1 reference

19 December 2017

issue

3

1 reference

19 December 2017

Targeting the PAS-A domain of HIF-1alpha for development of small molecule inhibitors of HIF-1.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

Melatonin modulates the expression of VEGF and HIF-1 alpha induced by CoCl2 in cultured cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

Hypoxia enhances LPA-induced HIF-1alpha and VEGF expression: their inhibition by resveratrol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

Estrogen-induced activation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor expression, and edema in the uterus are mediated by the phosphatidylinositol 3-kinase/Akt pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

VEGF and HIF-1alpha expression are increased in advanced stages of epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

Regulation of gene expression by the hypoxia-inducible factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

Cell-specific regulation of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha stabilization and transactivation in a graded oxygen environment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

A conserved family of prolyl-4-hydroxylases that modify HIF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

Resveratrol: a review of preclinical studies for human cancer prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

Overexpression of human papillomavirus type 16 oncoproteins enhances hypoxia-inducible factor 1 alpha protein accumulation and vascular endothelial growth factor expression in human cervical carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1alpha and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

Inhibition of tumour invasion and angiogenesis by epigallocatechin gallate (EGCG), a major component of green tea.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

Reduced risk of esophageal cancer associated with green tea consumption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

Tea and coffee consumption and the risk of digestive tract cancers: data from a comparative case-referent study in Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

A case-control study of gastric cancer and diet in northern Kyushu, Japan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

Green tea consumption and the risk of pancreatic and colorectal cancers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

Influence of drinking green tea on breast cancer malignancy among Japanese patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

trans-3,4,5'-Trihydroxystibene inhibits hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in human ovarian cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

Neoangiogenesis and expression of hypoxia-inducible factor 1alpha, vascular endothelial growth factor, and glucose transporter-1 in endometrioid type endometrium adenocarcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

Hypoxia-inducible factor-1 in human breast and prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

Diet and cancer risk in Mediterranean countries: open issues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

Green tea extract and (-)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1alpha protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

Epigallocatechin gallate inhibits HIF-1alpha degradation in prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

Hypoxia-inducible factor-1 activation by (-)-epicatechin gallate: potential adverse effects of cancer chemoprevention with high-dose green tea extracts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

10.1016/J.YGYNO.2009.02.014

7 January 2021

Identifiers

DOI

1 reference

19 December 2017

PubMed ID

19321194

1 reference

19 December 2017